DEXIS and Henry Schein Sign Agreement to Offer DEXIS Digital Radiography Products to Dental Customers.

MELVILLE, N.Y. -- DEXIS(R) and Henry Schein, Inc. (Nasdaq: HSIC) today announced a new agreement for the distribution of the DEXIS suite of products and services. Through this alliance, Henry Schein will work with DEXIS to market, sell and service all DEXIS products and services, including the DEXIS PerfectSize(TM) Sensor, PC Card, digital camera and imaging software. DEXIS is an industry leader in digital radiography.

"Following the rapid expansion of our suite of dental equipment products and services during this past year, we recognize that distribution plays a critical role in helping to accelerate our growth and in leveraging our various brands and product offerings," said Michael Donohoe, President, DEXIS. "Henry Schein's extensive reach into the dental professional community and leading position within the practice management software market with products such as DENTRIX(R) and Easy Dental(R), coupled with an appreciation of our technology and a proven ability to communicate these important benefits to customers, makes them an ideal partner for building the DEXIS brand."

"We are dedicated to offering our dental customers the best possible products and services to enhance their practices, and the DEXIS digital radiography line certainly fits that description," said James P. Breslawski, President and Chief Operating Officer of Henry Schein. "The DEXIS sensor delivers excellent image quality, is easy to use, and provides a great degree of patient comfort, so it is understandable why it is among the industry's leading solutions. This new agreement further enhances the value that we can offer to our more than 100,000 dental customers throughout the United States and Canada."

About DEXIS

DEXIS has achieved nearly 50 percent annual sales growth worldwide since it was founded in 1995, and maintained an even greater rate of growth in the United States since its introduction here in 1997. DEXIS was the first to introduce digital radiography systems featuring laptop computers, and the company's innovative PerfectSize(TM) rounded-edge sensor enhanced patient comfort by eliminating the sharp edges of film and other digital sensors. In 2001, DEXIS was the first company to have its digital radiography system receive the American Dental Association's seal of approval when it was admitted into the prestigious ADA Acceptance Program. It also was awarded the 2004 and 2005 Reality Magazine five-star award for outstanding digital radiography system.

About Henry Schein

Henry Schein, a Fortune 500(R) company, is recognized for its excellent customer service and highly competitive prices. The Company's four business groups--Dental, Medical, International and Technology--serve more than 475,000 customers worldwide, including dental practices and laboratories, physician practices and veterinary clinics, as well as government and other institutions. The Company's sales reached a record $4.1 billion in 2004. The Company operates through a centralized and automated distribution network, which provides customers in more than 125 countries with a comprehensive selection of over 160,000 national and Henry Schein private-brand products. Henry Schein also offers a wide range of innovative value-added practice solutions, including such leading practice management software systems as DENTRIX(R) and Easy Dental(R) for dental practices, and AVImark(R) for veterinary clinics, which are installed in over 50,000 practices; and ArubA(R), Henry Schein's electronic catalog and ordering system.

Headquartered in Melville, N.Y., Henry Schein employs nearly 11,000 people and has operations in 19 countries. For more information, visit the Henry Schein Web site at www.henryschein.com.

In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, the Company provides the following cautionary remarks regarding important factors which, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guaranties of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance and achievements, or industry results to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements.

These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate," or other comparable terms. A full discussion of the Company's operations and financial condition, including factors that may affect its business and future prospects, is contained in documents the Company has filed with the SEC and will be contained in all subsequent periodic filings made with the SEC. These documents identify in detail important risk factors that could cause the Company's actual performance to differ materially from current expectations.

Risk factors and uncertainties which could cause actual results to differ materially from current and historical results include, but are not limited to: competitive factors; changes in the healthcare industry; changes in government regulations that affect the Company; financial risks associated with the Company's international operations; fluctuations in quarterly earnings; transitional challenges associated with acquisitions; regulatory and litigation risks; the dependence on the Company's continued product development, technical support and successful marketing in the technology segment; the Company's dependence upon sales personnel and key customers; the Company's dependence on its senior management; the Company's dependence on third parties for the manufacture and supply of its products; possible increases in the cost of shipping the Company's products or other service trouble with the Company's third-party shippers; risks from rapid technological change; and risks from potential increases in variable interest rates.

The order in which these factors appear should not be construed to indicate their relative importance or priority. The Company cautions that these factors may not be exhaustive and that many of these factors are beyond the Company's ability to control or predict. Accordingly, forward-looking statements should not be relied upon as a prediction of actual results. The Company undertakes no duty and has no obligation to update forward-looking statements.